Characterisation of mutations in cytogenetically normal acute myeloid leukaemia patients with triple-negative FLT3-ITD/ NPM1/CEBPA subgroup using targeted next-generation sequencing. Int. Med. Res. J. 2026;11(1). doi:10.63719/imrj.2025.11.01.003